Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is not a standard combination drug product but rather four separate medications (acetylsalicylic acid, acetaminophen, diclofenac, and naproxen) that are sometimes used in various dual combinations for pain management. Each has different mechanisms of action and safety profiles. * **Acetylsalicylic acid** (aspirin) - A nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes and preventing platelet aggregation. * **Acetaminophen** (paracetamol) - An analgesic and antipyretic that likely works through central mechanisms by activating descending serotonergic pathways. * **Diclofenac** - A non-selective cyclooxygenase inhibitor NSAID that alters peripheral pain transmission pathways through anti-inflammatory mechanisms. * **Naproxen** - Another NSAID that works by inhibiting cyclooxygenase enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetylsalicylic acid + acetaminophen + diclofenac + naproxen.